COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) - 12/05/21
COVID19 et leucémies lymphoblastiques aiguës de l’enfant et de l’adolescent: recommandations actualisées (Version 2) du Comité « Leucémies » de la Société Française de lutte contre les Cancers et leucémies de l’Enfant et l’adolescent (SFCE)
for the Leukemia Committee of the SFCE
Summary |
Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations. Here is the second version of these recommendations updated according to the evolution of knowledge on COVID19.
Le texte complet de cet article est disponible en PDF.Keywords : SARS-CoV-2, COVID 19, Acute lymphoblastic leukemia, Children, Adolescents
Plan
Vol 108 - N° 5
P. 490-500 - mai 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.